Is Diverting Loop Ileostomy Necessary in Completion Proctectomy With Ileal Pouch Anal- Anastomosis: A Multicentre, Randomized Study of the GETAID Chirurgie Group. IDEAL Trial (IDEAL)
Primary Purpose
Ulcerative Colitis, Ileostomy - Stoma
Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
ileal pouch-anal anastomosis with diverting loop ileastomy
ileal pouch-anal anastomosis with diverting loop ileastomy
Sponsored by
About this trial
This is an interventional prevention trial for Ulcerative Colitis
Eligibility Criteria
Inclusion Criteria:
- patients aged ≥ 18 years,
- patients presenting with ulcerative colitis or indeterminate colitis requiring completion proctectomy
- patients who have given informed consent
Exclusion Criteria:
- indication for total proctocolectomy in one-stage or traditional 2-stage fashion
- Crohn's disease,
- pelvic radiotherapy,
- indication for total mésorectum excision
- vulnerable patient under the French laws
Sites / Locations
- Assistance Publique Hôpitaux de MarseilleRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Experimental
Control
Arm Description
ileal pouch-anal anastomosis without diverting loop ileostomy
ileal pouch-anal anastomosis with diverting loop ileostomy
Outcomes
Primary Outcome Measures
6-month global postoperative morbidity
Number and qualification of surgical and medical complications that may require redmission during the 6 months following the operative procedure:
SBO
ileostomy prolapse
parastomial hernia
dehydration
skin erosions, that may require readmission
anastomotic leakage
incisional hernia.
Secondary Outcome Measures
Full Information
NCT ID
NCT03872271
First Posted
March 11, 2019
Last Updated
February 3, 2023
Sponsor
Assistance Publique Hopitaux De Marseille
1. Study Identification
Unique Protocol Identification Number
NCT03872271
Brief Title
Is Diverting Loop Ileostomy Necessary in Completion Proctectomy With Ileal Pouch Anal- Anastomosis: A Multicentre, Randomized Study of the GETAID Chirurgie Group. IDEAL Trial
Acronym
IDEAL
Official Title
Is Diverting Loop Ileostomy Necessary in Completion Proctectomy With Ileal Pouch Anal- Anastomosis: A Multicentre, Randomized Study of the GETAID Chirurgie Group. IDEAL Trial
Study Type
Interventional
2. Study Status
Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 26, 2019 (Actual)
Primary Completion Date
May 24, 2024 (Anticipated)
Study Completion Date
May 24, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique Hopitaux De Marseille
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Defunctioning ileostomy has demonstrated its benefits (rate and seriousness of anastomotic leakage) in cancer for low colorectal and coloanal anastomoses, whereas there are no such good quality evidences in case of ileal pouch-anal anastomosis (IPAA) performed for inflammatory bowel disease (IBD). However, most surgical teams do protect systematically IPAA by an ileostomy.
Total proctocolectomy with IPAA is the gold standard for surgical management of ulcerative colitis (UC). This demanding procedure is often performed in 2 or 3 stages, namely subtotal colectomy, completion proctectomy with IPAA and defunctioning ileostomy closure. Subtotal colectomy with double stoma is first performed to allow nutritional support, reduce inflammation and stop immunosuppressive agents. Completion proctectomy with IPAA is then performed on a healthier patient. Hence, the need for a systematic defunctioning ileostomy is questioned. No study addressed specifically the question of completion proctectomy, whereas it concerns 36% to 42% of patients undergoing IPAA. Globally, the overall 6-month morbidity rate is 55% in case of stoma creation vs. 30% otherwise in IPAA.
Moreover, defunctioning ileostomy has several drawbacks including an additional surgical procedure (stoma closure), a worse quality of life before closure, and the risk of dehydration that may require readmission. Following stoma closure, the risk of anastomotic leakage is around 4%. Overall, during the stoma period, 8% of patients will require reoperation. Finally, the risk of incisional hernia is 15-20% at the ex-ileostomy site.
Therefore, the aim of this trial is to assess the need for a systematic defunctioning ileostomy after completion proctectomy with IPAA.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ulcerative Colitis, Ileostomy - Stoma
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
194 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Experimental
Arm Type
Experimental
Arm Description
ileal pouch-anal anastomosis without diverting loop ileostomy
Arm Title
Control
Arm Type
Active Comparator
Arm Description
ileal pouch-anal anastomosis with diverting loop ileostomy
Intervention Type
Procedure
Intervention Name(s)
ileal pouch-anal anastomosis with diverting loop ileastomy
Intervention Description
Defunctioning ileostomy has demonstrated its benefits (rate and seriousness of anastomotic leakage) in cancer for low colorectal and coloanal anastomoses, whereas there are no such good quality evidences in case of ileal pouch-anal anastomosis (IPAA) performed for inflammatory bowel disease (IBD). However, most surgical teams do protect systematically IPAA by an ileostomy.
Intervention Type
Procedure
Intervention Name(s)
ileal pouch-anal anastomosis with diverting loop ileastomy
Intervention Description
Defunctioning ileostomy has demonstrated its benefits (rate and seriousness of anastomotic leakage) in cancer for low colorectal and coloanal anastomoses, whereas there are no such good quality evidences in case of ileal pouch-anal anastomosis (IPAA) performed for inflammatory bowel disease (IBD). However, most surgical teams do protect systematically IPAA by an ileostomy.
Primary Outcome Measure Information:
Title
6-month global postoperative morbidity
Description
Number and qualification of surgical and medical complications that may require redmission during the 6 months following the operative procedure:
SBO
ileostomy prolapse
parastomial hernia
dehydration
skin erosions, that may require readmission
anastomotic leakage
incisional hernia.
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patients aged ≥ 18 years,
patients presenting with ulcerative colitis or indeterminate colitis requiring completion proctectomy
patients who have given informed consent
Exclusion Criteria:
indication for total proctocolectomy in one-stage or traditional 2-stage fashion
Crohn's disease,
pelvic radiotherapy,
indication for total mésorectum excision
vulnerable patient under the French laws
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Laura BEYER, MD
Phone
0491968514
Email
laura.beyer@ap-hm.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Amandine Rolland-Brun
Phone
0491381245
Email
promotion.interne@ap-hm.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
EMILIE GARRIDO PRADALIE
Organizational Affiliation
AP-HM
Official's Role
Study Director
Facility Information:
Facility Name
Assistance Publique Hôpitaux de Marseille
City
Marseille
ZIP/Postal Code
13354
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Laura Beyer, MD
Email
laura.beyer@ap-hm.fr
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
31830976
Citation
Beyer-Berjot L, Baumstarck K, Loubiere S, Vicaut E, Berdah SV, Benoist S, Lefevre JH; GETAID Chirurgie group. Is diverting loop ileostomy necessary for completion proctectomy with ileal pouch-anal anastomosis? A multicenter randomized trial of the GETAID Chirurgie group (IDEAL trial): rationale and design (NCT03872271). BMC Surg. 2019 Dec 12;19(1):192. doi: 10.1186/s12893-019-0657-7.
Results Reference
derived
Learn more about this trial
Is Diverting Loop Ileostomy Necessary in Completion Proctectomy With Ileal Pouch Anal- Anastomosis: A Multicentre, Randomized Study of the GETAID Chirurgie Group. IDEAL Trial
We'll reach out to this number within 24 hrs